Gene Study for Autosomal Dominant Hearing Loss

Natural History of Autosomal Dominant Hearing Loss

Recruiting Observational Study
Hearing Loss
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 – 99
Sex
Any
Study type
Observational
Participants needed
1,100 (estimated)
Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD) · NIH
Who this trial is looking for

This trial is looking for people aged 3 to 99 with hereditary hearing loss and their family members. Participants will have hearing tests, balance tests, and some may provide blood or skin samples for gene testing.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have hereditary hearing loss confirmed by genetic testing
  • I am a family member of someone with hereditary hearing loss
  • I am a healthy family member of an enrolled participant
  • I can provide informed consent or have a parent/guardian who can
  • I am between 3 and 99 years old

You may not be able to join if

  • I have hearing loss from an infection or illness
  • I have hearing loss due to medication like cisplatin
  • I have hearing loss from surgery like acoustic neuroma removal
  • I cannot provide informed consent due to cognitive impairment

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Background: Hereditary hearing loss is one of the most common sensory disabilities affecting newborns. The main options for people with hereditary hearing loss are hearing aids and cochlear implants. Both options have their limitations and do not restore biological hearing. Researchers want to learn if gene editing might be a treatment option. Objective: To understand the genes that cause non-s…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: * Affected persons with autosomal dominant hereditary sensorineural hearing loss, preferably confirmed by prior genetic testing * Affected family members of enrolled participants with known autosomal dominant hereditary hearing loss * Unaffected Family Members (Healthy Voluntee…
Contacts

Maame S Akumatey

(227) 233-0452

maame.akumatey@nih.gov

CONTACT

Joshua M Levy, M.D.

(240) 935-8305

joshua.levy@nih.gov

CONTACT